388 related articles for article (PubMed ID: 15670771)
1. Stable siRNA-mediated silencing of antizyme inhibitor: regulation of ornithine decarboxylase activity.
Choi KS; Suh YH; Kim WH; Lee TH; Jung MH
Biochem Biophys Res Commun; 2005 Mar; 328(1):206-12. PubMed ID: 15670771
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cell proliferation by the antizyme inhibitor: evidence for an antizyme-independent mechanism.
Kim SW; Mangold U; Waghorne C; Mobascher A; Shantz L; Banyard J; Zetter BR
J Cell Sci; 2006 Jun; 119(Pt 12):2583-91. PubMed ID: 16735445
[TBL] [Abstract][Full Text] [Related]
3. Antizyme inhibitor is rapidly induced in growth-stimulated mouse fibroblasts and releases ornithine decarboxylase from antizyme suppression.
Nilsson J; Grahn B; Heby O
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):699-704. PubMed ID: 10698696
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of antizyme-inhibitor in NIH3T3 fibroblasts provides growth advantage through neutralization of antizyme functions.
Keren-Paz A; Bercovich Z; Porat Z; Erez O; Brener O; Kahana C
Oncogene; 2006 Aug; 25(37):5163-72. PubMed ID: 16568078
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor.
Kahana C
Essays Biochem; 2009 Nov; 46():47-61. PubMed ID: 20095969
[TBL] [Abstract][Full Text] [Related]
7. Antizyme inhibitor: a defective ornithine decarboxylase or a physiological regulator of polyamine biosynthesis and cellular proliferation.
Keren-Paz A; Bercovich Z; Kahana C
Biochem Soc Trans; 2007 Apr; 35(Pt 2):311-3. PubMed ID: 17371267
[TBL] [Abstract][Full Text] [Related]
8. Regulation of all members of the antizyme family by antizyme inhibitor.
Mangold U; Leberer E
Biochem J; 2005 Jan; 385(Pt 1):21-8. PubMed ID: 15355308
[TBL] [Abstract][Full Text] [Related]
9. Nuclear translocation of antizyme and expression of ornithine decarboxylase and antizyme are developmentally regulated.
Gritli-Linde A; Nilsson J; Bohlooly-Y M; Heby O; Linde A
Dev Dyn; 2001 Mar; 220(3):259-75. PubMed ID: 11241834
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding.
Almrud JJ; Oliveira MA; Kern AD; Grishin NV; Phillips MA; Hackert ML
J Mol Biol; 2000 Jan; 295(1):7-16. PubMed ID: 10623504
[TBL] [Abstract][Full Text] [Related]
11. Antizyme 3 inhibits polyamine uptake and ornithine decarboxylase (ODC) activity, but does not stimulate ODC degradation.
Snapir Z; Keren-Paz A; Bercovich Z; Kahana C
Biochem J; 2009 Apr; 419(1):99-103, 1 p following 103. PubMed ID: 19076071
[TBL] [Abstract][Full Text] [Related]
12. Docking of antizyme to ornithine decarboxylase and antizyme inhibitor using experimental mutant and double-mutant cycle data.
Cohavi O; Tobi D; Schreiber G
J Mol Biol; 2009 Jul; 390(3):503-15. PubMed ID: 19465028
[TBL] [Abstract][Full Text] [Related]
13. The antizyme family for regulating polyamines.
Kahana C
J Biol Chem; 2018 Nov; 293(48):18730-18735. PubMed ID: 30355739
[TBL] [Abstract][Full Text] [Related]
14. ODCp, a brain- and testis-specific ornithine decarboxylase paralogue, functions as an antizyme inhibitor, although less efficiently than AzI1.
Snapir Z; Keren-Paz A; Bercovich Z; Kahana C
Biochem J; 2008 Mar; 410(3):613-9. PubMed ID: 18062773
[TBL] [Abstract][Full Text] [Related]
15. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
Hurta RA; Lee J; Voskas D
J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
[TBL] [Abstract][Full Text] [Related]
16. Developmental alterations in expression and subcellular localization of antizyme and antizyme inhibitor and their functional importance in the murine mammary gland.
Murakami Y; Suzuki J; Samejima K; Oka T
Amino Acids; 2010 Feb; 38(2):591-601. PubMed ID: 19997757
[TBL] [Abstract][Full Text] [Related]
17. Human ornithine decarboxylase paralogue (ODCp) is an antizyme inhibitor but not an arginine decarboxylase.
Kanerva K; Mäkitie LT; Pelander A; Heiskala M; Andersson LC
Biochem J; 2008 Jan; 409(1):187-92. PubMed ID: 17900240
[TBL] [Abstract][Full Text] [Related]
18. Degradation of ornithine decarboxylase by the 26S proteasome.
Murakami Y; Matsufuji S; Hayashi S; Tanahashi N; Tanaka K
Biochem Biophys Res Commun; 2000 Jan; 267(1):1-6. PubMed ID: 10623564
[TBL] [Abstract][Full Text] [Related]
19. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
Voskas D; Mader R; Lee J; Hurta RA
Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
[TBL] [Abstract][Full Text] [Related]
20. Expression of a novel human ornithine decarboxylase-like protein in the central nervous system and testes.
Pitkänen LT; Heiskala M; Andersson LC
Biochem Biophys Res Commun; 2001 Oct; 287(5):1051-7. PubMed ID: 11587527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
